. c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. Hum Mol Genet. 2014 Jun 1;23(11):2858-79. Epub 2014 Jan 9 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Potential Parkinson’s Treatments Target α-Synuclein, Cell Replacement

Therapeutics

  1. Nilotinib
  2. Vodobatinib